BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO. Gene therapy for the nervous system: challenges and new strategies. Neurotherapeutics 2014;11:817-39. [PMID: 25159276 DOI: 10.1007/s13311-014-0299-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Godoy LD, Prizon T, Rossignoli MT, Leite JP, Liberato JL. Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention. Front Integr Neurosci 2022;16:765324. [DOI: 10.3389/fnint.2022.765324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Giotta Lucifero A, Luzzi S. Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II). Brain Sci 2021;11:976. [PMID: 34439595 DOI: 10.3390/brainsci11080976] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Miterko LN, Lin T, Zhou J, van der Heijden ME, Beckinghausen J, White JJ, Sillitoe RV. Neuromodulation of the cerebellum rescues movement in a mouse model of ataxia. Nat Commun 2021;12:1295. [PMID: 33637754 DOI: 10.1038/s41467-021-21417-8] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
4 Caballero-Villarraso J, Sawas J, Escribano BM, Martín-Hersog FA, Valverde-Martínez A, Túnez I. Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes. Expert Rev Neurother 2021;21:431-41. [PMID: 33554666 DOI: 10.1080/14737175.2021.1886926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Iqubal A, Iqubal MK, Khan A, Ali J, Baboota S, Haque SE. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective. CGT 2020;20:184-94. [DOI: 10.2174/1566523220999200716111502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Humbel M, Ramosaj M, Zimmer V, Regio S, Aeby L, Moser S, Boizot A, Sipion M, Rey M, Déglon N. Maximizing lentiviral vector gene transfer in the CNS. Gene Ther 2021;28:75-88. [PMID: 32632267 DOI: 10.1038/s41434-020-0172-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Giotta Lucifero A, Luzzi S, Brambilla I, Guarracino C, Mosconi M, Foiadelli T, Savasta S. Gene therapies for high-grade gliomas: from the bench to the bedside. Acta Biomed 2020;91:32-50. [PMID: 32608374 DOI: 10.23750/abm.v91i7-S.9953] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Croci S, Carriero ML, Capitani K, Daga S, Donati F, Frullanti E, Lamacchia V, Tita R, Giliberti A, Valentino F, Benetti E, Ciabattini A, Furini S, Lo Rizzo C, Pinto AM, Conticello SG, Renieri A, Meloni I. High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot. Eur J Hum Genet 2020;28:1231-42. [PMID: 32332872 DOI: 10.1038/s41431-020-0624-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Olaciregui NG, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K, Hajitou A. Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma. EMBO Mol Med 2019;11:e8492. [PMID: 30808679 DOI: 10.15252/emmm.201708492] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
10 Al Qtaish N, Gallego I, Villate-Beitia I, Sainz-Ramos M, López-Méndez TB, Grijalvo S, Eritja R, Soto-Sánchez C, Martínez-Navarrete G, Fernández E, Puras G, Pedraz JL. Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues. Pharmaceutics 2020;12:E198. [PMID: 32106545 DOI: 10.3390/pharmaceutics12030198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
11 Taghian T, Marosfoi MG, Puri AS, Cataltepe OI, King RM, Diffie EB, Maguire AS, Martin DR, Fernau D, Batista AR, Kuchel T, Christou C, Perumal R, Chandra S, Gamlin PD, Bertrand SG, Flotte TR, McKenna-Yasek D, Tai PWL, Aronin N, Gounis MJ, Sena-Esteves M, Gray-Edwards HL. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna. Mol Ther 2020;28:411-21. [PMID: 31813800 DOI: 10.1016/j.ymthe.2019.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
12 Keaveney MK, Tseng HA, Ta TL, Gritton HJ, Man HY, Han X. A MicroRNA-Based Gene-Targeting Tool for Virally Labeling Interneurons in the Rodent Cortex. Cell Rep 2018;24:294-303. [PMID: 29996091 DOI: 10.1016/j.celrep.2018.06.049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
13 Pena SA, Iyengar R, Eshraghi RS, Bencie N, Mittal J, Aljohani A, Mittal R, Eshraghi AA. Gene therapy for neurological disorders: challenges and recent advancements. Journal of Drug Targeting 2020;28:111-28. [DOI: 10.1080/1061186x.2019.1630415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Bäck S, Dossat A, Parkkinen I, Koivula P, Airavaara M, Richie CT, Chen YH, Wang Y, Harvey BK. Neuronal Activation Stimulates Cytomegalovirus Promoter-Driven Transgene Expression. Mol Ther Methods Clin Dev 2019;14:180-8. [PMID: 31380464 DOI: 10.1016/j.omtm.2019.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Munis AM, Mattiuzzo G, Bentley EM, Collins MK, Eyles JE, Takeuchi Y. Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery. Mol Ther Nucleic Acids 2019;17:126-37. [PMID: 31254925 DOI: 10.1016/j.omtn.2019.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
16 Luo J, Padhi P, Jin H, Anantharam V, Zenitsky G, Wang Q, Willette AA, Kanthasamy A, Kanthasamy AG. Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson's Disease. J Neuroimmune Pharmacol 2019;14:595-607. [PMID: 30879240 DOI: 10.1007/s11481-019-09844-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Bardakjian TM, Naczi KF, Gonzalez-Alegre P. Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease. J Huntingtons Dis 2019;8:79-85. [PMID: 30689592 DOI: 10.3233/JHD-180328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Butti Z, Patten SA. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front Genet 2018;9:712. [PMID: 30723494 DOI: 10.3389/fgene.2018.00712] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 19.0] [Reference Citation Analysis]
19 Teng YD, Abd-El-Barr M, Wang L, Hajiali H, Wu L, Zafonte RD. Spinal cord astrocytomas: progresses in experimental and clinical investigations for developing recovery neurobiology-based novel therapies. Exp Neurol 2019;311:135-47. [PMID: 30243796 DOI: 10.1016/j.expneurol.2018.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mashal M, Attia N, Soto-Sánchez C, Martínez-Navarrete G, Fernández E, Puras G, Pedraz JL. Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain. Int J Pharm 2018;552:48-55. [PMID: 30244145 DOI: 10.1016/j.ijpharm.2018.09.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
21 Mashal M, Attia N, Soto-Sánchez C, Martínez-Navarrete G, Fernández E, Puras G, Pedraz JL. WITHDRAWN: Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain. Int J Pharm 2018:S0378-5173(18)30365-X. [PMID: 29802899 DOI: 10.1016/j.ijpharm.2018.05.057] [Reference Citation Analysis]
22 Annoni A, Gregori S, Naldini L, Cantore A. Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell Immunol 2019;342:103802. [PMID: 29735164 DOI: 10.1016/j.cellimm.2018.04.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
23 Clarke AJ, Abdala Sheikh AP. A perspective on "cure" for Rett syndrome. Orphanet J Rare Dis 2018;13:44. [PMID: 29609636 DOI: 10.1186/s13023-018-0786-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
24 Gerakis Y, Hetz C. Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease. FEBS J 2018;285:995-1011. [PMID: 29148236 DOI: 10.1111/febs.14332] [Cited by in Crossref: 94] [Cited by in F6Publishing: 117] [Article Influence: 18.8] [Reference Citation Analysis]
25 Antyborzec I, O'Leary VB, Dolly JO, Ovsepian SV. Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain. Neurotherapeutics 2016;13:859-70. [PMID: 27220617 DOI: 10.1007/s13311-016-0445-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Afkhami S, Renardy Y. Ferrofluids and magnetically guided superparamagnetic particles in flows: a review of simulations and modeling. J Eng Math 2017;107:231-51. [DOI: 10.1007/s10665-017-9931-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
27 Naumova AV, Vande Velde G. Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging: Iron-associated proteins as MRI reporters. WIREs Nanomed Nanobiotechnol 2018;10:e1482. [DOI: 10.1002/wnan.1482] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
28 Collongues N, Michel L, de Seze J. Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications. Curr Treat Options Neurol 2017;19. [DOI: 10.1007/s11940-017-0456-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Pignataro D, Sucunza D, Vanrell L, Lopez-Franco E, Dopeso-Reyes IG, Vales A, Hommel M, Rico AJ, Lanciego JL, Gonzalez-Aseguinolaza G. Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System. Front Neuroanat 2017;11:2. [PMID: 28239341 DOI: 10.3389/fnana.2017.00002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
30 Niu S, Zhang LK, Zhang L, Zhuang S, Zhan X, Chen WY, Du S, Yin L, You R, Li CH, Guan YQ. Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model. Theranostics 2017;7:344-56. [PMID: 28042339 DOI: 10.7150/thno.16562] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 17.4] [Reference Citation Analysis]
31 Merkel SF, Andrews AM, Lutton EM, Mu D, Hudry E, Hyman BT, Maguire CA, Ramirez SH. Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem 2017;140:216-30. [PMID: 27718541 DOI: 10.1111/jnc.13861] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
32 LeVaillant CJ, Sharma A, Muhling J, Wheeler LP, Cozens GS, Hellström M, Rodger J, Harvey AR. Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF. Mol Ther Methods Clin Dev 2016;3:16078. [PMID: 27933306 DOI: 10.1038/mtm.2016.78] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
33 Polinski NK, Manfredsson FP, Benskey MJ, Fischer DL, Kemp CJ, Steece-Collier K, Sandoval IM, Paumier KL, Sortwell CE. Impact of age and vector construct on striatal and nigral transgene expression. Mol Ther Methods Clin Dev 2016;3:16082. [PMID: 27933309 DOI: 10.1038/mtm.2016.82] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
34 Bhadra U, Patra P, Chhatai J, Pal-Bhadra M. Pigmy MicroRNA: surveillance cops in Therapies kingdom. Mol Med 2016;22:759-75. [PMID: 27704139 DOI: 10.2119/molmed.2016.00136] [Reference Citation Analysis]
35 Saraiva J, Nobre RJ, Pereira de Almeida L. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9. J Control Release 2016;241:94-109. [PMID: 27637390 DOI: 10.1016/j.jconrel.2016.09.011] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 15.0] [Reference Citation Analysis]
36 van Zundert B, Brown RH Jr. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci Lett 2017;636:32-9. [PMID: 27507699 DOI: 10.1016/j.neulet.2016.07.059] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
37 de Leeuw CN, Korecki AJ, Berry GE, Hickmott JW, Lam SL, Lengyell TC, Bonaguro RJ, Borretta LJ, Chopra V, Chou AY, D'Souza CA, Kaspieva O, Laprise S, McInerny SC, Portales-Casamar E, Swanson-Newman MI, Wong K, Yang GS, Zhou M, Jones SJ, Holt RA, Asokan A, Goldowitz D, Wasserman WW, Simpson EM. rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Mol Brain 2016;9:52. [PMID: 27164903 DOI: 10.1186/s13041-016-0232-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
38 El-Shamayleh Y, Ni AM, Horwitz GD. Strategies for targeting primate neural circuits with viral vectors. J Neurophysiol 2016;116:122-34. [PMID: 27052579 DOI: 10.1152/jn.00087.2016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
39 Zappulli V, Friis KP, Fitzpatrick Z, Maguire CA, Breakefield XO. Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest 2016;126:1198-207. [PMID: 27035811 DOI: 10.1172/JCI81134] [Cited by in Crossref: 117] [Cited by in F6Publishing: 128] [Article Influence: 19.5] [Reference Citation Analysis]
40 Choudhury SR, Hudry E, Maguire CA, Sena-Esteves M, Breakefield XO, Grandi P. Viral vectors for therapy of neurologic diseases. Neuropharmacology 2017;120:63-80. [PMID: 26905292 DOI: 10.1016/j.neuropharm.2016.02.013] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 13.0] [Reference Citation Analysis]
41 Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, Wu WL, Yang B, Huber N, Pasca SP, Gradinaru V. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol 2016;34:204-9. [PMID: 26829320 DOI: 10.1038/nbt.3440] [Cited by in Crossref: 417] [Cited by in F6Publishing: 451] [Article Influence: 69.5] [Reference Citation Analysis]
42 Javed H, Menon SA, Al-Mansoori KM, Al-Wandi A, Majbour NK, Ardah MT, Varghese S, Vaikath NN, Haque ME, Azzouz M, El-Agnaf OM. Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders. Mol Ther 2016;24:746-58. [PMID: 26700614 DOI: 10.1038/mt.2015.232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
43 Ferraro TN. Barriers to the use of genetic information for the development of new epilepsy treatments. Expert Rev Neurother 2016;16:5-8. [PMID: 26559170 DOI: 10.1586/14737175.2016.1115718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Song C, Knöpfel T. Optogenetics enlightens neuroscience drug discovery. Nat Rev Drug Discov 2016;15:97-109. [DOI: 10.1038/nrd.2015.15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
45 Worman HJ, Dauer WT. The nuclear envelope: an intriguing focal point for neurogenetic disease. Neurotherapeutics 2014;11:764-72. [PMID: 25119890 DOI: 10.1007/s13311-014-0296-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
46 Dauer WT. Neurogenetic disease: genes, mechanisms, and future promise. Neurotherapeutics 2014;11:697-8. [PMID: 25261113 DOI: 10.1007/s13311-014-0303-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
47 Chen X, Zhao X, Hu Y, Lan F, Sun H, Fan G, Sun Y, Wu J, Kong W, Kong W. The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young rats. Gene Ther 2015;22:866-75. [PMID: 26125607 DOI: 10.1038/gt.2015.63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Prabhakar S, Zhang X, Goto J, Han S, Lai C, Bronson R, Sena-Esteves M, Ramesh V, Stemmer-Rachamimov A, Kwiatkowski DJ, Breakefield XO. Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. Neurobiol Dis 2015;82:22-31. [PMID: 26019056 DOI: 10.1016/j.nbd.2015.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
49 Hill JM, Clement C, Zhao Y, Lukiw WJ. Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses. Front Microbiol 2015;6:43. [PMID: 25691883 DOI: 10.3389/fmicb.2015.00043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
50 Quick Q, Paul M, Skalli O. Roles and potential clinical applications of intermediate filament proteins in brain tumors. Semin Pediatr Neurol 2015;22:40-8. [PMID: 25976260 DOI: 10.1016/j.spen.2014.12.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]